Skip to content

The Incidence of Thoracic Disc Herniation in Patients Presenting With Chronic Upper Back Pain

The Incidence of Thoracic Disc Herniation in Patients Presenting With Chronic Upper Back Pain, A Follow-Up Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05313997
Enrollment
194
Registered
2022-04-06
Start date
2022-05-24
Completion date
2022-07-15
Last updated
2022-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thoracic Disc Herniation

Keywords

chronic upper back pain, thoracic disc herniation

Brief summary

Patients who applied to the Private Medar Hospital between February 2016 and February 2021 with chronic upper back pain and were diagnosed with Thoaracic Disc Herniatin (TDH) (with Thoracic vertebral MRI) and followed up for at least 1 year will be included in the study. Patients diagnosed with TDH were included in the medical treatment and/or physical therapy program. Before and after these treatment programs, the pain intensity of the patients was recorded with the visual analog scale (VAS). The number of patients who applied to the Physical Medicine and Rehabilitation outpatient clinic with chronic upper back pain between February 2016 and February 2021 will be researched, and the demographic characteristics of those diagnosed with TDH will be selected and recorded in their files, their pre- and post-treatment VAS scores, and the results will be analyzed statistically.

Interventions

DRUGDiclofenac Sodium

at first diclofenac sodium was prescribed to patients with chronic upper back pain. If the patient's pain persisted, she/he was included in the physical therapy (hotpack 20 minutes, ultrason 5 minutes, Transcutaneous electrical nerve stimulation 20 minutes) program.

Sponsors

Kocaeli University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years

Inclusion criteria

* 18-65 years old * admitted to the Private Medar Hospital Gölcük hospital between February 2016 and February 2021 with chronic upper back pain. * Diagnosed with TDH as a result of thoracic vertebral MRI

Exclusion criteria

Patients with * vertebral fracture, * developmental spinal deformity, * spinal infection or tumor, * chronic widespread pain syndrome such as fibromyalgia, * diabetes mellitus, * polyneuropathy * rheumatological disease * under 18 years old * over 65 years old * who have had previous back and neck surgery

Design outcomes

Primary

MeasureTime frameDescription
Visual Analog Scale (VAS)10 secondsThe Visual Analog Scale (VAS) is usually a 100-mm long horizontal line with verbal descriptors (word anchors) at each end to express the extremes of the feeling. FM patients mark the point on the line that best corresponds to their symptom severity. To this end, they are instructed to put a cross on the straight line at the point that most accurately expresses their degree of agreement. When reading the VAS, the position of the respondent's cross is generally assigned a score between 0 and 100. If documented in paper form, the scores can then be simply transferred to a 100- value scale using a millimeter tape measure.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026